Redoxis is a preclinical CRO with focus on inflammation and autoimmune conditions. They provide in vivo of RA, MS, GBS and SLE. In addition, they have a fully equipped lab with capacity to perform in vitro and ex vivo follow up assays and a wide range of immunology assays to provide you everything form MoA studies to PK and in vivo efficacy